SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-070939
Filing Date
2023-12-18
Accepted
2023-12-18 07:37:57
Documents
2
Period of Report
2023-12-18

Document Format Files

Seq Description Document Type Size
1 6-K 6-k_letter_from_ceo_dec_.htm 6-K 26154
2 EX-99.1 vrax-ex99_1.htm EX-99.1 23305
  Complete submission text file 0000950170-23-070939.txt   50599
Mailing Address 30 BROADWICK STREET LONDON X0 W1F 8LX
Business Address 30 BROADWICK STREET LONDON X0 W1F 8LX 44 020 7788 7414
Virax Biolabs Group Ltd (Filer) CIK: 0001885827 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41440 | Film No.: 231492243
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)